Retinopathy of prematurity: screening programme for preterm infants in Ondo State, South-West, Nigeria


  • Stella A. Adegbehingbe Department of Ophthalmology, University of Medical Sciences Teaching Hospital, Akure, Nigeria
  • Rosena O. Oluwafemi Department of Paediatrics and Child Health, University of Medical Sciences Teaching Hospital, Akure, Nigeria



ROP, Prematurity, Prevalence, Ondo State


Background: Retinopathy of prematurity (ROP) is one of the avoidable causes of childhood blindness in the whole world. The disease can be mild, it can resolve spontaneously, and it could also have a grave consequence of blindness. As such, all extreme and very preterm babies at risk for ROP and having additional systemic co-morbidities and risk factors must be screened.

Methods: Preterm babies with gestational age up to 32 weeks and birth weight less than 1500 g were prospectively recruited into the study. Retinal examination using binocular indirect ophthalmoscope with +20DS lens was done at 4 to 6 weeks post-delivery and were subsequently followed up. Data were analyzed using the software package for social science (SPSS) version 20.0 Categorized data were presented as percentages, p value <0.05 was considered significant.

Results: Fifty-two preterm babies with birth weight ranging between 900-1500 g and gestational age ranging between 26-32 weeks were examined. ROP was detected in 7 babies (13.5%), Four (57.1%) babies had stage 1 ROP, 3 (42.9%) had stage 2 disease and none had stage 3 disease. ROP was commoner in the female babies 6 (86%). Neonatal sepsis and use of up to 3-days supplemental oxygen therapy (p=0.024) were the only risk factors associated with all the babies with ROP in the study.

Conclusions: Prevalence of ROP was 13.5% in the current study with risk factors of neonatal sepsis and use of supplemental oxygen of up to 72 hours post-natal life.


Gilbert C, Foster A. Childhood blindness in the context of VISION 2020—the right to sight. Bull World Health Org. 2001;79(3):227-32.

Bowling B. A systemic Approach: Eyelids. In: Kanski’s Clinical Ophthamology. 8th edition. Elsevier Limited. 2016;561.

Sabri K, Ells AL, Lee EY, Dutta S, Vinekar A. Retinopathy of Prematurity: A Global Perspective and Recent Developments. Pediatrics. 2022;150(3):e2021053924.

Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(1):35-49.

Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. International No-Rop Group. Characteristics of Infants with Severe Retinopathy of Prematurity in Countries with Low, Moderate, and High Levels of Development: Implications for Screening Programs. Pediatrics. 2005;115(5):e518-25.

Hong EH, Shin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr. 2022;65(3):115-26.

Ademola-Popoola D, Adesi- yun O, Durotoye IA, Obasa TO. Screening programme for retinopathy of prematurity in Ilorin, Nigeria: a pilot study. West Afr J Med. 2013;32(4):281-5.

Oluwafemi RO, Abiodun MT. Incidence and outcome of preterm deliveries in Mother and Child Hospital Akure, Southwestern, Nigeria. Sri Lanka J Child Health. 2016;45(1):11-7.

International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-9.

Braimah IZ, Enweronu-Laryea C, Sackey AH, Kenu E, Agyabeng K, Ofori-Adjei ID, et al. Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: A baseline prospective study. BMJ Open. 2020;10:e035341.

Olusanya BA, Oluleye TS, Tango OO, Ugalahi MO, Babalola YO, Ayede AI, et al. Retinopathy of prematurity in a tertiary facility: An initial report of a screening programme. Niger J Paediatr. 2020;47:55-60.

Fajolu IB, Rotimi-Samuel A, Aribaba OT, Musa KO, Akinsola FB, Ezeaka VC, et al. Retinopathy of prematurity and associated factors in Lagos, Nigeria. Paediatr Int Child Health. 2015;35:324-8.

Nkanga ED, Agweye CT, Etim BA, Ochigbo SO, Udoh MM, Nkanga DG, et al. Retinopathy of prematurity in the University of Calabar Teaching, Calabar, Nigeria: An early report of a screening service. J West Afr Coll Surg. 2021;11:6-12.

Basiri B, Sabzehei MK, Shokouhi SM, Akbarzadeh S, Ivazeh S. Frequency and risk factors of retinopathy of prematurity in new-borns admitted to neonatal intensive care unit in Hamadan. Avicenna J Clin Med. 2019;26:44-50.

Onyango O, Sitati S, Amolo L, Murila F, Wariua S, Nyamu G, et al. Retinopathy of prematurity in Kenya: Prevalence and risk factors in a hospital with advanced neonatal care. Pan Afr Med J. 2018;29:152.

Adio AO, Ugwu RO, Nwokocha CG, Eneh AU. Retinopathy of prematurity in Port Harcourt, Nigeria. ISRN Ophthalmol. 2014;10:1-6.

Ademola-Popoola DS, Fajolu IB, Gilbert C. Strengthening retinopathy of prematurity screening and treatment services in Nigeria: a case study of activities, challenges and outcomes 2017-2020. BMJ Open Ophthalmol. 2021;6:e000645.

Quinn GE. Retinopathy of prematurity blindness worldwide: Phenotypes in the third epidemic. Eye Brain. 2016;8:31-6.

Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology. 2004;111:1317-25.

Jalali S, Matalia J, Hussain A, Anand R. Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries. Am J Ophthalmol. 2006;141:966-8.




How to Cite

Adegbehingbe, S. A., & Oluwafemi, R. O. (2024). Retinopathy of prematurity: screening programme for preterm infants in Ondo State, South-West, Nigeria. International Journal of Research in Medical Sciences, 12(6), 1857–1862.



Original Research Articles